Effects of Bothrops asper snake venom on the expression of cyclooxygenases and production of prostaglandins by peritoneal leukocytes in vivo, and by isolated neutrophils and macrophages in vitro

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 80, Issue 2-3, 2009, Pages 107-114

  Moreira, Vanessa ^a   Gutiérrez, José María ^b   Amaral, Rafaela Bacci ^a   Zamunér, Stella Regina ^a   Teixeira, Catarina de Fátima Pereira ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Cyclooxygenases; Macrophage; Neutrophil; Snake venom

Indexed keywords

BOTHROPS ASPER VENOM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS;

ANIMALS; ASCITIC FLUID; BIOCATALYSIS; BOTHROPS; CELL SURVIVAL; CROTALID VENOMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; INJECTIONS, INTRAPERITONEAL; LEUKOCYTES; MACROPHAGES, PERITONEAL; MALE; MEMBRANE PROTEINS; MICE; NEUTROPHILS; PERITONEAL CAVITY; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS;

BOTHROPS ASPER;

EID: 61849179292     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2008.11.009     Document Type: Article

References (61)

1. Gómez H., and Dart R.C. Clinical toxicology of snakebite in north America. In: Meier J., and White J. (Eds). Handbook of Clinical Toxicology of Animal Venoms and Poisons (1995), CRC Press, Boca Raton 619-644
2. Gutiérrez J.M. Clinical toxicology of snakebite in Central America. In: Meier J., and White J. (Eds). Handbook of Clinical Toxicology of Animal Venoms and Poisons (1995), CRC Press, Boca Raton, FL 667-668
3. Fan W.H., and Cardoso J.L. Clinical toxicology of snakebite in North America. In: Meier J., and White J. (Eds). Handbook of Clinical Toxicology of Animal Venoms and Poisons (1995), CRC Press, Boca Raton, FL 667-688
4. Warrel D.A. Clinical features of envenoming from snake bites. In: Bon C., and Goyffon M. (Eds). Envenoming and their Treatments (1996), Editions Foundation Marcel Mérieux, Lyon 63-76
5. Rosenfeld G. Symptomatology, pathology and treatment of snake bites in South America. In: Bucherl W., and Buckley E. (Eds). Venomous Animals and Their Venoms Venomous Vertebrates vol. II (1971), Academic Press, New York 345-384
6. Teixeira C.F.P., Zamunér S.R., Zuliani J.P., Fernandes C.M., Cruz-Hofling M.A., Fernandes I., Chaves F., and Gutiérrez J.M. Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Botrhops asper snake venom. Muscle Nerve 28 (2003) 449-459
7. Zamunér S.R., Gutiérrez J.M., Muscará M.N., Teixeira S.A., and Teixeira C.F.P. Bothrops asper and Bothrops jararaca snake venoms trigger microbicidal functions of peritoneal leukocytes in vivo. Toxicon 39 (2001) 1505-1513
8. Zamunér S.R., Zuliani J.P., Fernandes C.M., Gutiérrez J.M., and Teixeira C.F.P. Inflammation induced by Bothrops asper venom: release of proinflammatory cytokines and eicosanoids, and role of adhesion molecules in leukocyte infiltration. Toxicon 46 (2005) 806-813
9. Teixeira C.F.P., Cury Y., Oga S., and Jancar S. Hyperalgesia induced by Bothrops jararaca venom in rats: role of eicosanoids and platelet activating factor (PAF). Toxicon 32 (1994) 419-426
10. Chaves F., Barbosa M., and Gutiérrez J.M. Pharmacological study of edema induced by venom of the snake Bothrops asper (Terciopelo) in mice. Toxicon 33 (1995) 31-39
11. Chaves F., Teixeira C.F., and Gutiérrez J.M. Role of TNF-alpha, IL-1 beta and IL-6 in the local tissue damage induced by Bothrops asper snake venom: an experimental assessment in mice. Toxicon 45 (2005) 171-178
12. Chacur M., Picolo G., Gutiérrez J.M., Teixeira C.F.P., and Cury Y. Pharmacological modulation of hyperalgesia induced by Bothrops asper (terciopelo) snake venom. Toxicon 39 (2001) 1173-1181
13. Smith W., and Marnett L. Prostaglandin endoperoxide synthase: structure and catalysis. Biochem. Biophys. Acta 1083 (1991) 1-17
14. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23 (2002) 144-150
15. Narumiya S., and Fitzgerald G.A. Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 108 (2001) 25-30
16. Rocca B., and Fitzgerald G.A. Cyclooxygenases and prostaglandins: shaping up the immune response. Int. Immunopharmacol. 2 (2002) 603-630
17. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
18. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med. 184 (1996) 883-891
19. Nakamura M., and Ferreira S.H. A peripheral sympathetic component in inflammatory hyperalgesia. Eur. J. Pharmacol. 135 (1987) 145-153
20. Cunha F.Q., Lorenzetti B.B., Poole S., and Ferreira S.H. Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol. 104 (1991) 765-767
21. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107 (1992) 660-664
22. Ferreira S.H., Lorenzetti B.B., and Poole S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. 110 (1993) 1227-1231
23. Poole S., Lorenzetti B.B., Cunha J.M., Cunha F.Q., and Ferreira S.H. Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br. J. Pharmacol. 126 (1999) 649-656
24. Reddy S.T., and Herschman H.R. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J. Biol. Chem. 269 (1994) 15473-15480
25. Morham S.G., Langenbach R.R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., and Smith W.L. The eicosanoids and their biochemical mechanisms of action. Biochem. J. 259 (1989) 315-324
26. 2. Prostaglandins 35 (1988) 277-300
27. 2 is suggested by distribution studies of the rat DP prostanoid receptor. Eur. J. Pharmacol. 377 (1999) 101-115
28. Kanaoka Y., and Urade Y. Hematopoietic prostaglandin D synthase. Prostaglandins Leukot. Essent. Fatty Acids 69 (2003) 163-167
29. Hart P.H. Regulation of the inflammatory response in asthma by mast cell products. Immunol. Cell Biol. 79 (2001) 149-153
30. 2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells. Circ. Res. 82 (1998) 204-209
31. 2 into human airways during acute antigen challenge. N. Engl. J. Med. 315 (1986) 800-804
32. 2 from human skin in vivo and in vitro during immediate allergic reactions. Br. J. Pharmacol. 94 (1988) 773-780
33. Smith S., Deitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
34. Herschmann H.R. Prostaglandin synthase 2. Biochim. Biophys. Acta 1299 (1996) 125-140
35. Smith W.L., and Langenbach R. Why there are two cyclooxygenase isozymes?. J. Clin. Invest. 107 (2001) 1491-1495
36. Ford-Hutchinson A.W., Bray M.A., and Smith M.J. Lipoxygenase products and the polymorphonuclear leucocyte. Agents Actions 10 (1980) 548-550
37. Zurier R.B. Prostaglandin release from human polymorphonuclear leukocytes. Adv. Prostaglandin Thromboxane Res. 2 (1976) 815-818
38. Pradelles P., Grassi J., and Mac Louf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal. Chem. 57 (1985) 1170-1173
39. Olivo R.A., Teixeira C.F.P., Wallace J.L., Gutiérrez J.M., and Zamunér S.R. Role of cyclooxygenases in oedema-forming activity of bothropic venoms. Toxicon 49 (2007) 670-677
40. 2, and expression of cyclooxygenases. Toxicon 49 (2007) 615-624
41. Herschman H.R. Function and regulation of prostaglandin synthase 2. Adv. Exp. Med. Biol. 469 (1999) 3-8
42. 2: a biochemical perspective. Prostaglandins Leukot. Essent. Fatty Acids 37 (1989) 219-234
43. James M.J., Penglis P.S., Caughey G.E., Demasi M., and Clenland L.G. Eicosanoids production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?. Inflamm. Res. 50 (2001) 249-253
44. 2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. J. Pharmacol. Exp. Ther. 303 (2002) 1001-1006
45. Hartert T.V., Dworski R.T., Mellen B.G., Oates J.A., Murray J.J., and Sheller J.R. Prostaglandin E(2) decreases allergen stimulated release of prostaglandin D(2) in airways of subjects with asthma. Am. J. Respir. Crit. Care Med. 162 (2000) 637-640
46. 2 production by IFN-γ in human macrophages. J. Immunol. 161 (1998) 2441-2448
47. Diaz A., Chepenik K.P., Korn J.H., Reginato A.M., and Jimenez S.A. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp. Cell Res. 241 (1998) 222-229
48. Petricevich V.L., Teixeira C.F.P., Tambourgi D.V., and Gutiérrez J.M. Increments in cytokine and nitric oxide serum levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms. Toxicon 38 (2000) 1253-1266
49. James M.J., Penglis P.S., Caughey G.E., Demasi M., and Cleland L.G. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?. Inflamm. Res. 50 (2001) 249-253
50. 2 in regulating arachidonic acid release and prostaglandin generation. Implications on cyclooxygenase-2 induction and phospholipids scramblase-mediated cellular membrane perturbation. J. Biol. Chem. 274 (1999) 31435-33144
51. 2 in mouse bone marrow-derived mast cells. J. Biol. Chem. 269 (1994) 22269-22275
52. 2 generation in rat 3Y1 fibroblasts. J. Biol. Chem. 273 (1998) 1733-1740
53. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular Biology. Annu. Rev. Biochem. 69 (2000) 145-182
54. 2s. Biochim. Biophys. Acta 1488 (2000) 159-166
55. 2 myotoxins from Bothrops snake venoms. Toxicon 33 (1995) 1405-1424
56. Wilborn J., DeWitt D.L., and Peters-Golden M. Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages. Am. J. Physiol. 268 (1995) L294-L301
57. Gordon S. The macrophage. Bioessays 17 (1995) 977-986
58. Kay A.B. Leucocytes in asthma. Immunol. Invest. 17 (1988) 679-705
59. Maloney C.G., Kutchera W.A., Albertine K.H., Mcintyre T.M., Prescott S.M., and Zimmerman G.A. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J. Immunol. 160 (1998) 1402-1410
60. Crawford R.M., Leiby D.A., Green S.J., Nacy C.A., Fortier A.H., and Meltzer M.S. Macrophage activation: a riddle of immunological resistance. Immunol. Ser. 60 (1994) 29-46
61. Scapini P., Lapinet-Vera J.A., Gasperini S., Calzetti F., Bazzoni F., and Cassatella M.A. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177 (2000) 195-203